Literature DB >> 8890243

Proteins in the cell wall and membrane of Cryptococcus neoformans stimulate lymphocytes from both adults and fetal cord blood to proliferate.

C H Mody1, K L Sims, C J Wood, R M Syme, J C Spurrell, M M Sexton.   

Abstract

Cryptococcus neoformans is an encapsulated yeast that infects patients who have defective cell-mediated immunity, including AIDS, but rarely infects individuals who have intact cell-mediated immunity. Studies of the immune response to C. neoformans have been hampered by a paucity of defined T-lymphocyte antigens, and hence, the understanding of the T-cell response is incomplete. The goal of this study was to separate C. neoformans into its component parts, determine whether those components stimulate lymphocyte proliferation, perform preliminary characterization of the proteins, and establish the potential mechanism of lymphocyte proliferation. The lymphocyte response to fungal culture medium, whole organisms, disrupted organisms, and the yeast intracellular fraction or cell wall and membrane was studied by determining thymidine incorporation and by determining the number of lymphocytes at various times after stimulation. The cell wall and membrane of C. neoformans stimulated lymphocyte proliferation, while the intracellular fraction and culture filtrate did not. The optimal response occurred on day 7 of incubation, with 4 x 10(5) peripheral blood mononuclear cells per well and with 13 microg of cryptococcal protein per ml. The number of lymphocytes increased with time in culture, indicating that thymidine incorporation was accompanied by proliferation. Proteinase K treatment of the cell wall and membrane abrogated lymphocyte proliferation, indicating that the molecule was a protein. [35S]methionine labeling, sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and fluorography were performed to analyze the proteins contained in the cell wall and membrane, intracellular fraction, and culture filtrate. At least 18 discrete bands were resolved from the cell wall and membrane. Since a large percentage of healthy adults responded to the cryptococcal cell wall and membrane, a mitogenic effect was investigated by testing proliferation of fetal cord blood lymphocytes. The percentage of fetal samples that proliferated in response to the cell wall and membrane was similar to the percentage of fetal samples that proliferated in response to Staphylococcus enterotoxin B, a microbial mitogen. Thus, a protein in the cell wall and membrane of C. neoformans is a potent stimulant of lymphocyte proliferation and has mitogenic properties, which may have important implications for cell-mediated immunity to C. neoformans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8890243      PMCID: PMC174449          DOI: 10.1128/iai.64.11.4811-4819.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

2.  Depletion of murine CD8+ T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans.

Authors:  C H Mody; G H Chen; C Jackson; J L Curtis; G B Toews
Journal:  J Lab Clin Med       Date:  1993-06

Review 3.  Polysaccharide antigens of the capsule of Cryptococcus neoformans.

Authors:  R Cherniak; J B Sundstrom
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

4.  CD8 cells play a critical role in delayed type hypersensitivity to intact Cryptococcus neoformans.

Authors:  C H Mody; R Paine; C Jackson; G H Chen; G B Toews
Journal:  J Immunol       Date:  1994-04-15       Impact factor: 5.422

5.  In vivo depletion of murine CD8 positive T cells impairs survival during infection with a highly virulent strain of Cryptococcus neoformans.

Authors:  C H Mody; G H Chen; C Jackson; J L Curtis; G B Toews
Journal:  Mycopathologia       Date:  1994-01       Impact factor: 2.574

6.  The glucuronoxylomannan of Cryptococcus neoformans serotype A is a type 2 T-cell-independent antigen.

Authors:  J B Sundstrom; R Cherniak
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

7.  Occurrences, specificities, and functions of ubiquitous antibodies in human serum that are reactive with the Cryptococcus neoformans cell wall.

Authors:  R G Keller; G S Pfrommer; T R Kozel
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

8.  Effect of polysaccharide capsule and methods of preparation on human lymphocyte proliferation in response to Cryptococcus neoformans.

Authors:  C H Mody; R M Syme
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

9.  Determination of antigen binding specificities of Cryptococcus neoformans factor sera by enzyme-linked immunosorbent assay.

Authors:  T Belay; R Cherniak
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

10.  Occurrences, immunoglobulin classes, and biological activities of antibodies in normal human serum that are reactive with Cryptococcus neoformans glucuronoxylomannan.

Authors:  D C Houpt; G S Pfrommer; B J Young; T A Larson; T R Kozel
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

View more
  10 in total

1.  Extracellular proteins of Cryptococcus neoformans and host antibody response.

Authors:  L C Chen; L A Pirofski; A Casadevall
Journal:  Infect Immun       Date:  1997-07       Impact factor: 3.441

2.  Characterization of Lipids and Proteins Associated to the Cell Wall of the Acapsular Mutant Cryptococcus neoformans Cap 67.

Authors:  Larissa V G Longo; Ernesto S Nakayasu; Jhon H S Pires; Felipe Gazos-Lopes; Milene C Vallejo; Tiago J P Sobreira; Igor C Almeida; Rosana Puccia
Journal:  J Eukaryot Microbiol       Date:  2015-03-23       Impact factor: 3.346

3.  Primary dendritic cells phagocytose Cryptococcus neoformans via mannose receptors and Fcgamma receptor II for presentation to T lymphocytes.

Authors:  Rachel M Syme; Jason C L Spurrell; Ernest K Amankwah; Francis H Y Green; Christopher H Mody
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

Review 4.  Prospects for the development of fungal vaccines.

Authors:  G S Deepe
Journal:  Clin Microbiol Rev       Date:  1997-10       Impact factor: 26.132

5.  Phagocytosis and protein processing are required for presentation of Cryptococcus neoformans mitogen to T lymphocytes.

Authors:  R M Syme; J C Spurrell; L L Ma; F H Green; C H Mody
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

6.  Diversity of the T-cell response to pulmonary Cryptococcus neoformans infection.

Authors:  Dennis M Lindell; Megan N Ballinger; Roderick A McDonald; Galen B Toews; Gary B Huffnagle
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

Review 7.  Direct microbicidal activity of cytotoxic T-lymphocytes.

Authors:  Paul Oykhman; Christopher H Mody
Journal:  J Biomed Biotechnol       Date:  2010-06-23

8.  The cell wall and membrane of Cryptococcus neoformans possess a mitogen for human T lymphocytes.

Authors:  C H Mody; C J Wood; R M Syme; J C Spurrell
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

9.  Identification of the fungal ligand triggering cytotoxic PRR-mediated NK cell killing of Cryptococcus and Candida.

Authors:  Shu Shun Li; Henry Ogbomo; Michael K Mansour; Richard F Xiang; Lian Szabo; Fay Munro; Priyanka Mukherjee; Roy A Mariuzza; Matthias Amrein; Jatin M Vyas; Stephen M Robbins; Christopher H Mody
Journal:  Nat Commun       Date:  2018-02-21       Impact factor: 14.919

10.  Adaptive Immunity to Cryptococcus neoformans Infections.

Authors:  Liliane Mukaremera; Kirsten Nielsen
Journal:  J Fungi (Basel)       Date:  2017-11-21
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.